2022
DOI: 10.4062/biomolther.2022.137
|View full text |Cite
|
Sign up to set email alerts
|

Growth Factors Upregulated by Uric Acid Affect Guanine Deaminase-Induced Melanogenesis

Abstract: Uric acid produced by guanine deaminase (GDA) is involved in photoaging and hyperpigmentation. Reactive oxygen species (ROS) generated by uric acid plays a role in photoaging. However, the mechanism by which uric acid stimulates melanogenesis in GDA-overexpressing keratinocytes is unclear. Keratinocyte-derived paracrine factors have been identified as important mechanisms of ultraviolet-induced melanogenesis. Therefore, the role of paracrine melanogenic growth factors in GDA-induced hypermelanosis mediated by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 35 publications
0
0
0
Order By: Relevance
“…Interestingly, in multiple myeloma patients, IMiDs increase the production of IFN-γ (an inhibitor of melanogenesis) from T cells, and IMiDs downregulate VEGF, bFGF, and granulocyte macrophage-colony stimulating factor (GM-CSF), all of which have promotive effects on melanogenesis [193,201,[209][210][211][212][213]. The hair repigmentation effects of IMiDs are primarily attributed to their ability to inhibit the elevated levels of melanogenic inhibitors observed in multiple myeloma patients.…”
Section: Immunomodulatory Drugsmentioning
confidence: 99%
“…Interestingly, in multiple myeloma patients, IMiDs increase the production of IFN-γ (an inhibitor of melanogenesis) from T cells, and IMiDs downregulate VEGF, bFGF, and granulocyte macrophage-colony stimulating factor (GM-CSF), all of which have promotive effects on melanogenesis [193,201,[209][210][211][212][213]. The hair repigmentation effects of IMiDs are primarily attributed to their ability to inhibit the elevated levels of melanogenic inhibitors observed in multiple myeloma patients.…”
Section: Immunomodulatory Drugsmentioning
confidence: 99%